What is the recommended azithromycin dosage for pediatric patients, including weight‑based dosing for children older than 6 months up to about 12 years and dosing for infants younger than 6 months?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Azithromycin Pediatric Dosing

Standard Dosing for Children ≥6 Months

For most pediatric infections in children 6 months and older, azithromycin should be dosed at 10 mg/kg (maximum 500 mg) on day 1, followed by 5 mg/kg once daily (maximum 250 mg/day) on days 2–5. 1

Indication-Specific Dosing (Children ≥6 Months)

  • Community-acquired pneumonia (atypical pathogens): 10 mg/kg day 1, then 5 mg/kg daily days 2–5 2, 1
  • Acute otitis media: Three FDA-approved regimens exist 1:
    • 10 mg/kg day 1, then 5 mg/kg daily days 2–5 (5-day regimen)
    • 10 mg/kg once daily for 3 days (3-day regimen)
    • 30 mg/kg as a single dose (1-day regimen)
  • Acute bacterial sinusitis: 10 mg/kg once daily for 3 days 1
  • Pharyngitis/tonsillitis (streptococcal): 12 mg/kg once daily for 5 days (maximum 500 mg/day) 1
    • Critical caveat: The standard 10 mg/kg dosing is inferior to penicillin for streptococcal pharyngitis; the higher 12 mg/kg dose is required 3, 1

Intravenous Dosing (Hospitalized Children)

  • Severe community-acquired pneumonia: 10 mg/kg IV on days 1 and 2, then transition to oral therapy 2, 3

Dosing for Infants <6 Months

For infants younger than 6 months, azithromycin dosing is 10 mg/kg once daily for 5 days. 4

Important Safety Consideration

  • Erythromycin (not azithromycin) carries risk of infantile hypertrophic pyloric stenosis (IHPS) in infants <1 month old 4
  • Azithromycin is the preferred macrolide for neonates and young infants when macrolide therapy is indicated 4
  • The specific indication studied in this age group was pertussis prophylaxis and treatment 4

Weight-Based Dosing Tables

5-Day Regimen (Community-Acquired Pneumonia, Otitis Media)

Weight Day 1 Dose Days 2–5 Dose Total Course
5 kg (11 lbs) 2.5 mL (100 mg/5 mL) 1.25 mL 150 mg [1]
10 kg (22 lbs) 5 mL 2.5 mL 300 mg [1]
20 kg (44 lbs) 5 mL (200 mg/5 mL) 2.5 mL 600 mg [1]
30 kg (66 lbs) 7.5 mL 3.75 mL 900 mg [1]
40 kg (88 lbs) 10 mL 5 mL 1200 mg [1]
≥50 kg (≥110 lbs) 12.5 mL 6.25 mL 1500 mg [1]

Pharyngitis/Tonsillitis (12 mg/kg × 5 days)

Weight Daily Dose (Days 1–5) Total Course
8 kg (18 lbs) 2.5 mL (200 mg/5 mL) 500 mg [1]
17 kg (37 lbs) 5 mL 1000 mg [1]
25 kg (55 lbs) 7.5 mL 1500 mg [1]
33 kg (73 lbs) 10 mL 2000 mg [1]
40 kg (88 lbs) 12.5 mL 2500 mg [1]

Key Clinical Pearls

Administration

  • Can be taken with or without food 1
  • Do not co-administer with aluminum- or magnesium-containing antacids (reduces absorption) 4

Common Pitfalls

  • Underdosing streptococcal pharyngitis: Using 10 mg/kg instead of the required 12 mg/kg leads to treatment failure and higher recurrence rates compared to penicillin 3, 1
  • Re-dosing after vomiting: For the single 30 mg/kg dose regimen in otitis media, safety of re-dosing has not been established; in clinical trials, patients who vomited within 30 minutes were re-dosed at the same total dose 1

Tolerability

  • Gastrointestinal adverse events occur in approximately 9–18% of pediatric patients, primarily diarrhea (3–6%), vomiting (2–6%), and abdominal pain (1–3%) 1, 5
  • Better tolerated than amoxicillin/clavulanate (4% vs 31% treatment-related adverse events in one study) 1
  • Higher doses (30 mg/kg single dose, 20 mg/kg daily) associated with more adverse effects but still generally well-tolerated 5

Resistance Considerations

  • Approximately 1% of azithromycin-susceptible S. pyogenes isolates become resistant following therapy 1
  • Inadequate dosing promotes antimicrobial resistance 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.